Videos

  • Presentation at the XVth World Congress of the Transplantation Society

    Video presentation from the World Congress discussing key findings and research in transplantation.

Online Presentations

  • Colon Cancer in Liver Transplant Recipients

    Medscape presentation discussing research findings on colon cancer occurrence and treatment in liver transplant patients.

  • Posttransplant Lymphoproliferative Disorders in Liver Transplantation

    A comprehensive 20-year experience study on lymphoproliferative disorders following liver transplantation.

Slide Presentations

  • Liver Transplantation in 4000 Consecutive Patients

    Analysis of 2-18 years follow-up study, examining cause of death and indications for retransplantation in 4000 consecutive liver transplant patients.

  • Intravenous Mycophenolate Mofetil Study

    Research on using intravenous mycophenolate mofetil and delayed introduction of low dose oral tacrolimus to preserve renal function in living donor liver transplantation.

  • Ribavirin Level Study

    Investigation into the relevance of ribavirin level in post liver transplant patients for recurrence of hepatitis C viral infection.

  • Tacrolimus for Primary Liver Transplantation

    12-15 years actual follow-up study in 1000 consecutive patients with safety profile analysis.

  • Valganciclovir Study in CMV Infection

    Research on the effectiveness of Valganciclovir hydrochloride (Valcyte™) in providing prophylaxis against Cytomegalovirus (CMV) infection in liver transplant recipients.

  • UW versus HTK Tissue Preservation Study

    Comparative analysis of University of Wisconsin (UW) versus histidine-tryptophan-ketoglutarate (HTK) for tissue preservation in live donor liver transplantation.

Research Posters

  • HCV Antibody Study

    Research on the correlation of hepatitis C viral (HCV) antibody titre with hepatitis C viral load, hepatic injury and response to anti-HCV treatment in post liver transplant patients.

  • Hepatic Retransplantation for HCV

    Analysis of survival outcomes after hepatic retransplantation for hepatitis C viral positive and negative recipients.

  • Interferon Study

    Comparative study on safety and efficacy of pegylated interferon alfa-2b (Pegintron®) versus pegylated interferon alfa-2a (Pegasys®) in post liver transplant HCV genotype 1a/1b patients.

  • UW versus HTK Study (ESOT 2005)

    Research comparing University of Wisconsin (UW) versus histidine-tryptophan-ketoglutarate (HTK) preservation solutions in live donor liver transplantation.

  • Ribavirin Levels Study

    Analysis of ribavirin levels in post liver transplant patients treated for recurrent hepatitis C viral infection.